skip to content »

Pathology

Houston, Texas

Department of Pathology
Pathology
not shown on screen

Faculty

Carolina Gutierrez, M.D.Assistant Professor of Pathology

Dr. Gutierrez Collage

Education

  • M.D.

  • FCAP

Internship

  • Rotating Internship - National University of Colombia, Bogotá, Colombia

Residency

  • Anatomic Pathology - College of Physicians and Surgeons, Columbia University, New York, New York

Fellowship

  • Fellowship in Gynecologic Pathology. Division of Gynecologic and Obstetric Pathology, Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York

  • Fellowship in Breast Pathology, Section of Surgical Pathology, Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York

Post-doctoral Training

  • Fellowship in Immunohematology and Cytogenetics, Laboratory of Immunohematology, National Cancer Institute, Tokyo, Japan

  • Masters of Science Degree in Cellular Biology and Biochemistry, Department of Biology, New York University, New York

  • Fellowship in Cellular Immunology and Transplantation, Division of Immunogenetics, Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York

Specialty

  • Breast and GYN anatomic pathology

Board Certification

  • Anatomic Pathology 1994

Area of Interest

  • GYN and breast pathology

  • Translational research in breast cancer focusing on prognostic and predictive markers.

Current Position

  • Assistant Professor of Pathology, Department of Pathology, Baylor College of Medicine, Houston, Texas

Professional Positions Held

  • Assistant Professor, Department of Pathology, Baylor College of Medicine, 1999-present

  • Chairman, Department of Pathology, Fundacion Valle de Lilli Hospital, Cali Colombia, 1996-1999

  • Instructor Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York, 1994-1995

Other Positions

  • Director, Baylor College of Medicine Breast SPORE Pathology Core Laboratory

  • Co-Director, Baylor College of Medicine Breast SPORE National Tissue Resource

Honors and Awards

  • The Elaine B. Lesser Award for Gynecologic Cancer Investigation, Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York

  • Graduated in the top 15% of the National University Medical School, Bogotá, Colombia

Membership on professional organizations

  • American Society of Clinical Oncology

  • College of American Pathologists

Representative Publications

  1. Gutierrez, M.C., Detre, S., Johnston, S., Mohsin, S.K., Shou, J., Allred, D.C., Schiff, R. Osborne, C.K., Dowsett, M. Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship between ER, HER2, and p38 MAPK. JCO 23(11):2469-76, 2005.
  2. Mohsin, S.K., Weiss, H.L., Gutierrez, M.C., Chamness, G.C., Schiff, R., DiGiovanna, M.P., Wang, C-X., Hilsenbeck, S.G., Osborne, C.K., Allred, D.C., Elledge, R., Chang, J.C. Neoadjuvant trastuzumab induces apoptosis in primary breast cancers. JCO 23:2460-2468, 2005.
  3. Dowsett M, Johnston S, Martin LA, Salter J, Hills M, Detre S, Gutierrez MC, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK, Smith I. Growth factor signaling and response to endocrine therapy: the Royal Marsden Experience. Endocr Relat Cancer 2005 12(Suppl 1):S113-7.
  4. Tham, Y.L., Gomez, L.F., Mohsin, S., Gutierrez, M.C., Weiss, H., Hilsenbeck, S.G., Elledge, R.M., Chamness, G.C., Osborne, C.K., Allred, D.C., Chang, J.C. Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers. Breast Cancer Res Treat 2005 94(3):279-284.
  5. Chang, J.C., Wooten, E.C., Tsimelzon, A.. Hilsenbeck, S.G., Gutierrez, M.C., Tham, Y.L., Kalidas, M., Elledge, R., Mohsin, S., Osborne, C.K., Chamness, G.C., Allred, D.C., Lewis, M.T., Wong, H., O'Connell, P. Patterns of resistance and incomplete response to docetaxel (Taxotere™) by gene expression profiling in breast cancer patients. J Clin Oncol. 2005 Feb 20;23(6):1169-77.
  6. Chang, J.C., Wooten, E.C., Tsimelzon, A., Hilsenbeck, S.G., Gutierrez, M.C., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G., Allred D.C., O'Connell, P. Gene expression profiling predicts therapeutic response to docetaxel (Taxotere™) in breast cancer patients. Lancet. 2003 Aug 2;362(9381):362.